Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by ScienceFirston Jun 28, 2022 10:06am
294 Views
Post# 34787171

RE:RE:RE:RE:New Press Release - Theralase Expands Intellectual Property Portfolio

RE:RE:RE:RE:New Press Release - Theralase Expands Intellectual Property PortfolioLaserstock29 ... if you bought 8 years ago and that you still don't understand that running a SMB involves managing issues, opportunities, competition, long delays due to COVID-19, burn rate and priorities, then that's your problem.  By chance TLT management has not taken your advices as we would have lost opportunities like COVID-19 vaccines, etc ... and would have done a fire sale, giving them company for peanuts, with unrealized potential.

So far, we're on the verge of Breakthrough designation, so your "impatience" has no value and your simplistic vision is not impressing many.  Go post on CEO.ca.

TLT only has one chance to succeed, with limited financial revenues.  It requires focus and perseverance.
<< Previous
Bullboard Posts
Next >>